The Flow Cytometry Oncology Immunology market is expected to grow from an estimated USD 2.5 billion in 2024 to USD 6.7 billion in 2033, at a CAGR of 11.50%. The increased prevalence of HIV/AIDS is projected to drive the future growth of flow cytometry oncology and immunology market. HIV is a virus that assaults the immune system, primarily CD4 cells, which are white blood cells that fight...